---
title: "CareDx director Hannah Valantine disposes of common shares worth $1.04 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293071693.md"
description: "CareDx director Hannah Valantine sold 28,679 common shares on July 16, 2026, realizing approximately $1.04 million at an average price of $36.14 per share. She also exercised stock options for 28,779 shares priced between $7.96 and $20.56. Following these transactions, Valantine directly holds 36,686 shares."
datetime: "2026-07-17T20:23:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293071693.md)
  - [en](https://longbridge.com/en/news/293071693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293071693.md)
---

# CareDx director Hannah Valantine disposes of common shares worth $1.04 million

-   CareDx director Hannah Valantine reported a net sale of 28,679 shares on July 16, 2026. \* Sale priced at USD 36.14 a share; separate 100-share sale at USD 36.55. \* Also exercised stock options for 28,779 shares at USD 7.96 to USD 20.56. \* Directly held 36,686 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareDx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001855608-26-000004), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CDNA.US](https://longbridge.com/en/quote/CDNA.US.md)

## Related News & Research

- [CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News](https://longbridge.com/en/news/294561699.md)
- [CareDx Q2 revenue beats estimates; outlook lifted](https://longbridge.com/en/news/294409121.md)
- [CDNA: Q2 2026 revenue rose 52% to $132M, net income hit $111M, boosted by a major asset sale](https://longbridge.com/en/news/294409644.md)
- [CareDx (NASDAQ:CDNA) Sets New 1-Year High After Strong Earnings](https://longbridge.com/en/news/294521734.md)
- [CareDx CEO John Walter Hanna Jr disposes of USD 1.17 million in common shares](https://longbridge.com/en/news/291337174.md)